Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions. - Wikidata - wikimedia - TriplyDB

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.

http://www.wikidata.org/entity/Q34522899

about

Update in lung cancer and mesothelioma 2012 Next-generation sequencing to guide cancer therapy Molecular testing in lung cancer in the era of precision medicine Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Testing for ROS1 in non-small cell lung cancer: a review with recommendations From single-gene to multiplex analysis in lung cancer, challenges and accomplishments: a review of a single institution's experience.Molecular pathways and therapeutic targets in lung cancer RET fusion gene: translation to personalized lung cancer therapy Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.Molecular pathways: ROS1 fusion proteins in cancer.Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1.Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis.KAOS: a new automated computational method for the identification of overexpressed genes.Landscape of gene fusions in epithelial cancers: seq and ye shall find.Crystallization and preliminary X-ray crystallographic studies of the coiled-coil domain of PIST.RET rearrangements in lung adenocarcinoma and radiation Novel targets in non-small cell lung cancer: ROS1 and RET fusions Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells.Tyrosine kinase gene rearrangements in epithelial malignancies.RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Identification of cancer gene fusions based on advanced analysis of the human genome or transcriptome.Epidermal growth factor receptor mutations in lung adenocarcinoma.Prognostic and predictive biomarkers in lung cancer. A review.Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.Detecting and targetting oncogenic fusion proteins in the genomic era.Recent Advances in Targeting ROS1 in Lung Cancer.Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives.Lung Cancer in Never Smokers.ROS1 fusions in cancer: a review.Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR.

P2860

Q24619675-149C636A-AF21-4F3E-8C05-0A713CEF2EB0 Q26801946-E79AB83F-4A67-4C9E-889F-AD04A9713D6F Q26824599-6B9264D7-8DE9-4C46-915E-E89D801F3885 Q26828860-F7B71FDB-8D11-49E5-A42D-ACBC5D0C1507 Q28070062-33E0C6CE-7E44-43D5-9E80-F606F506749C Q28385559-10212BBD-334F-48A0-A11E-98C7856D97CE Q33688872-1019B4A1-E1CB-49BB-A70F-4559B8BBBEB0 Q33711282-15992D52-77C8-4DE0-960C-88DA7A3CD52F Q34092187-3F539102-F762-4F93-BF85-5F346933D296 Q34156513-663A29EC-6280-4706-8FBB-19868BE1004D Q34159011-B1B9DA1F-661B-4DC4-BBA9-B182B59D4415 Q34159334-38E00D1D-5AE9-439B-BA9D-BF49E2A3AF44 Q34347504-84E71FF2-9B7F-41CC-879E-F5C47611A7AB Q34781380-24D47FAB-AD0C-41E4-97F7-0D1B5E388868 Q35145481-BD6B9D3B-9FD4-4EC6-9BBA-1CBE7CB7902F Q35151926-1C6D7D6A-0D52-4E54-89B7-FA06AAF2F866 Q35168763-C564B2E4-6FCE-4611-92BB-EAC25B1124E4 Q35256622-4ECD07E1-B1BA-4C5C-963D-C74422B73B80 Q35545693-D3F9FE06-5C6B-4AF8-9F6F-C7337927BD8B Q36214500-BF51DC8C-18A6-4826-BF0F-58D12215F34E Q36276385-9EF4372D-3155-4894-91D1-52BCC199915D Q36383369-E6964039-3BDC-400D-AB9B-1A3C8B5C2D98 Q36734142-204BB7CD-0785-4ADF-AA73-40C1CC3AC698 Q36811473-79E7F8E2-25F6-4F3A-9C54-DD5B17829A74 Q37038500-F52D9209-1033-4699-A25B-C45FEF095EEF Q37236899-D5B3D3DF-73EB-4228-B5E1-00B92658BB11 Q37515966-CB9A61B1-2335-4C8D-924D-FFCEF930E185 Q37650677-534761E3-2331-49C4-99C2-CDB1575B09BE Q38105532-C898B91E-286A-40F6-A823-ED31AD4141D4 Q38117542-A5771312-5B87-4B73-BF2E-7D9A66991888 Q38174770-CEC45C44-648D-4C68-ADCB-4D91BD116668 Q38178187-D6293AA5-ABC0-4F63-B127-56067C09E947 Q38197071-97DCFDEB-725B-4E85-8845-E5D7CB6AB080 Q38213830-8FAF02C4-838E-4F97-9A05-8C9CB86E6600 Q38336067-9CA5E491-7DB3-4102-A7C3-588125C40502 Q38640765-781A4E2D-2B67-45E3-ADF9-1DE95EB23450 Q38652369-CA950DF2-4B66-4E8E-B5F3-E821D7948AEA Q38669269-BC7ADDA9-683F-4D58-AEDD-9840FE605392 Q38852070-4CE5CC39-E706-41E9-8552-A86FA80E3D8D Q38955578-45FF21F2-6D7A-452E-BAB2-FDEDBF562697

P2860

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.

http://www.wikidata.org/entity/Q34522899

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@ast

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@en

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@nl

type

label

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@ast

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@en

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@nl

prefLabel

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@ast

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@en

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@nl

P1433

Q34522899-EC6F285A-6839-4BDF-B26A-1FA7847E45A1

P1476

Q34522899-750B6A56-27A8-422C-BCC8-0D36458C9B8D

P2093

Q34522899-1E8C2C81-062A-4AB0-AD1A-557339EE40C4

Q34522899-2C3FA10F-589F-4F3B-A36E-E97C2CD28153

Q34522899-42381071-93AB-46B4-9D79-08B6D9C65D00

Q34522899-5CDA424B-86BE-43BC-9997-767310206011

Q34522899-75B7CE07-B8DF-49CB-90A7-5AADD3D24E82

Q34522899-88FD914A-0DEB-4627-BDA9-F58D9F472C96

Q34522899-89F5A673-B0F9-4941-AE20-B72AE2F9CBA2

Q34522899-97E3D3DE-0F01-43DD-9631-A49CBCBB62CA

Q34522899-AC837429-7E1B-4D65-8142-F0E08BC2F6EF

Q34522899-C67968B0-B73D-4F86-A158-052656B14991

P2860

Q34522899-032C04F8-2AB2-47B0-95F0-0138A2EE45A0

Q34522899-09C5B5DE-D416-4E6A-90E9-46AE71BADC97

Q34522899-23F68353-F5E5-4731-8DE7-A137FED906A8

Q34522899-2C2956E8-892A-403C-BE56-B947C0E8DFEF

Q34522899-2DB7AD08-BE57-429F-8F5D-246A29F2BE4F

Q34522899-317A846B-EAF8-4595-A43E-01748F20CF55

Q34522899-36CB844A-9337-42E3-96D3-553A666ABD11

Q34522899-36FE7829-A790-4DBD-8625-07BD555A29DC

Q34522899-44A78C76-CC0F-4B91-88AA-E9F737771FFF

Q34522899-4BA953BB-7DD3-4D1D-957D-9A76898980D0

P304

Q34522899-C42EF757-F415-4F82-8994-835206220BBA

P31

Q34522899-9404D6DF-D470-4292-BFAC-D4D5CB701A5D

P356

Q34522899-DBFF8C32-16C2-4042-A387-CDA8306B3BD7

P407

Q34522899-F7741D3A-80EC-438D-9978-997F12891A07

P433

Q34522899-0096903B-E59B-441A-83BD-E182C5625F6F

P478

Q34522899-8B3F3F1E-0AD2-4877-B518-C4AE1F33035F

P50

Q34522899-683C51A2-72D1-4B04-B4B5-D89B87C3D90E

Q34522899-B265BC0B-B392-4087-AEFE-CAE0B48176EC

Q34522899-D0110689-0EEC-4D9E-A004-566F41DC6F48

P577

Q34522899-64187D21-34E9-485C-BAA2-149E87FAB89C

P698

Q34522899-52AB5E74-94BE-4986-9D11-A44993686BD1

P921

Q34522899-7AE0DE51-2DAC-416A-A8A1-11A000503095

P932

Q34522899-3BD8A3CA-05F4-4113-AB75-C85EC0F74B89

P356

1078-0432.CCR-12-0838

P1433

Clinical Cancer Research

P1476

Identification of KIF5B-RET an ...... n for tyrosine kinase fusions.

@en

P2093

Adnan Hasanovic

http://www.w3.org/2001/XMLSchema#string

Alexander Drilon

http://www.w3.org/2001/XMLSchema#string

Daphne Ang

http://www.w3.org/2001/XMLSchema#string

Lu Wang

http://www.w3.org/2001/XMLSchema#string

Maria Arcila

http://www.w3.org/2001/XMLSchema#string

Maureen F Zakowski

http://www.w3.org/2001/XMLSchema#string

Naiyer Rizvi

http://www.w3.org/2001/XMLSchema#string

Raya Khanin

http://www.w3.org/2001/XMLSchema#string

Tatsuo Ito

http://www.w3.org/2001/XMLSchema#string

Udayan Guha

http://www.w3.org/2001/XMLSchema#string

P2860

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice

High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

ROS1 rearrangements define a unique molecular class of lung cancers.

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.

Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

P304

6599-6608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-12-0838

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Valerie W Rusch

P577

2012-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23052255

http://www.w3.org/2001/XMLSchema#string

P921

P932

4234119

http://www.w3.org/2001/XMLSchema#string